T1	Participants 64 101	Women with Polycystic Ovary Syndrome:
T2	Participants 310 354	women with polycystic ovary syndrome (PCOS).
T3	Participants 433 467	64 women with PCOS were randomized
T4	Participants 1615 1636	supplementation among
